Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It has accumulated the most preclinical evidence among peptides studied for musculoskeletal repair, including data relevant to spinal disc injuries
Above roughly 50-60 mcg/day, side-effect frequency rises faster than the perceived signaling benefit
10.1016/j.bbr.2020.112919 Summary Keywords retina, ischemia, BPC 157, L-NAME, rats Citation Zlatar M, Kokot A, Vuletic LB, Masnec S, Kralj T, Perisa MM, Barisic I, Radic B, Milanovic K, Drmic D, Seiwerth S and Sikiric P (2021) BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats
A blood test is the most reliable way to confirm whether B12 deficiency is a contributing factor
Documentation including certificates of analysis are available upon request for research validation purposes to support institutional compliance and grant requirements
Recalls & Warnings May 08, 2024 APG SEVEN Warned for Promoting Products for Cancer, Depression, Arthritis, & More On April 18, 2024, the FDA issued a Warning Letter to APG SEVEN, INC following a review of the companys product labels, website, and social media, which found statements about the companys BioMoringa, BioDiabetin, Maca Plus, BioProstate, Immune Support, HongoTrap, Honbacterol,
